GLP-1 cost with insurance for weight loss: 7 underrated checks
7 min read
Finding your GLP-1 cost with insurance for weight loss starts with one question: does your plan cover the drug for weight management at all? The answer varies by plan, state and diagnosis. Monthly prices run from $25 to well over $1,000, so the stakes are real. These seven checks turn a vague estimate into a number you can budget.
Start with the price you would pay without coverage
Without coverage, the bill is steep. The NCL weight-truth page puts the average list price of a month's GLP-1 supply at $936 to $1,349 when insurance does not cover the drug, and Maven Clinic says costs can top $1,000 a month. Medicaid data tells a similar story, because KFF reports that gross spending per GLP-1 prescription reached $1,000 in 2024, before rebates. These are benchmarks, not your bill, but they show what coverage is worth.
The GLP-1 cost with insurance for weight loss: seven checks to run
Run these in order and write down each answer. Your insurer's member line and your prescriber's office can settle most of them. Each check removes one unknown from the final number. Skip one and the estimate stays soft.
- Formulary status: ask whether Wegovy or Zepbound sits on your plan's drug list, and at what cost tier.
- Weight-loss exclusion: coverage for obesity is limited in most large employer plans, so ask whether yours includes it.
- Diagnosis on the prescription: ask which indication your plan requires, because rules differ by reason for use.
- Prior authorization: ask whether it is required, how long it takes and when it expires.
- Savings offer: with commercial insurance, ask your pharmacist about the manufacturer copay offer and its monthly cap.
- Cash comparison: price the self-pay route for the same drug and dose, then compare it with your copay.
- Non-drug fees: list visit, membership and shipping charges separately from the medication price.
Why the reason on your prescription changes coverage
The same pen can face different rules depending on why a doctor prescribes it. KFF's analysis of Medicaid GLP-1 coverage explains that states must cover nearly all FDA-approved drugs, but a long-standing statutory exception lets them decide on weight-loss drugs. As a result, obesity coverage is optional for states, while Medicaid coverage is generally required for GLP-1 medications prescribed for qualifying FDA-approved indications involving diabetes, cardiovascular risk reduction, and obstructive sleep apnea.
KFF notes that required Medicaid coverage reached Wegovy for cardiovascular use in March 2024 and Zepbound for sleep apnea in December 2024. Medicare follows a related pattern, since Novo Nordisk says Wegovy is covered through normal Part D benefits when prescribed to reduce major cardiovascular events in adults with established heart disease and obesity or overweight. Your prescriber sets the diagnosis based on your health. Costs and suitability vary, so ask them and your plan which route applies to you.
Prior authorization: timing and renewal
Most plans require prior authorization for this type of medicine, according to Novo Nordisk's Wegovy coverage page. Requests can take up to 10 business days, so ask your prescriber's office to file as soon as the prescription exists. Timing matters for your GLP-1 cost with insurance for weight loss, since coverage cannot apply until approval comes through. Approval also expires, and Novo Nordisk says a PA can stay valid from 30 days to more than a year, depending on coverage. Ask your insurer for the renewal date and what happens to your claim if it lapses.
Medicare and Medicaid follow different rules
Under current law, KFF notes, Medicare coverage of GLP-1s for obesity treatment is prohibited, so the Medicare GLP-1 Bridge Program fills the gap. Novo Nordisk says eligible patients pay $50 per month for Wegovy. Beginning July 1, 2026, the program is available nationwide through the end of 2027, covering all doses of the injection and the pill. CMS decides eligibility, and the offer is not a guarantee of coverage.
Lilly makes the same point on its Zepbound access and coverage page, tying eligibility to the Bridge clinical criteria. Walgreens adds that its $50 copayment covers the medication only, and visit costs are not included. For the Lilly side of the picture, read our guide on whether Medicare covers Zepbound for weight loss.
Medicaid works state by state. KFF counted 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026, after California, New Hampshire, Pennsylvania and South Carolina ended coverage. Where programs do cover them, controls such as prior authorization usually apply. Enrollees pay little or no copays, so the real question is whether your state covers the drug.
Savings offers and self-pay prices side by side
Your GLP-1 cost with insurance for weight loss also depends on which program pays the bill. With commercial coverage, the Wegovy savings offer can bring a copay to as little as $25, subject to a maximum savings of $100 per month, and government beneficiaries are excluded. Without coverage, prices depend on the product and dose, as the table shows. Our walkthrough on how to use a Wegovy copay card covers the steps for each payer.
| Route | Monthly price | Key condition |
|---|---|---|
| Commercial insurance plus savings offer | As little as $25 | Maximum savings of $100 per month; government beneficiaries excluded |
| Medicare GLP-1 Bridge | $50 | Eligibility set by CMS; runs through the end of 2027 |
| Wegovy pill, 1.5 mg | $149 | Fill through NovoCare Pharmacy or use the savings offer |
| Wegovy pill, 4 mg | $199 | Fill through NovoCare Pharmacy or use the savings offer |
| Wegovy pill, 9 mg or 25 mg | $299 | Fill through NovoCare Pharmacy or use the savings offer |
| Wegovy pen, 0.25 mg or 0.5 mg, new patients | $199 | Two monthly fills through December 31, 2026 |
| Wegovy pen, 0.25 mg to 2.4 mg, after that | $349 | Eligibility and restrictions apply |
| Wegovy HD pen, 7.2 mg | $399 | Eligibility and restrictions apply |
These figures come from Novo Nordisk's Wegovy pricing page. Novo Nordisk reserves the right to change or end the programs, so confirm the terms before you commit. Also compare like with like. A telehealth membership, a visit charge and the drug are three separate costs, so ask for each one in writing. Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy or Zepbound, so their prices do not line up with the figures above.
What to do after a denial
A denial is not the end of the route. Novo Nordisk says your doctor can file an appeal or request a peer-to-peer review with your insurer. With employer coverage, the doctor can also send a formal coverage request letter to your HR department. If your plan still says no, the self-pay routes above stay open.
Some plans list one branded drug and not the other, so ask whether the alternative is on the formulary. Our comparison of Zepbound vs Wegovy when coverage decides shows how that plays out. Your prescriber decides whether any change suits you. For Wegovy coverage questions, Novo Nordisk's line is 1-888-809-3942, Monday to Friday, 8 am to 8 pm ET.
Action steps
- Call your insurer: Ask whether Wegovy or Zepbound is covered for weight management, at what tier, and whether your employer excluded it.
- Confirm the diagnosis: Ask your prescriber which indication applies to you and what documentation your plan needs.
- Start the prior authorization: Have the office file as soon as the prescription is written, and note the renewal date.
- Price every route: Compare your copay, the manufacturer savings offer, Medicare Bridge if eligible, and the self-pay price for your dose.
- Add the non-drug fees: Write down visit, membership and shipping charges so you see the true all-in monthly cost.
Frequently asked questions
How much does Wegovy cost with commercial insurance?
Novo Nordisk says a copay could be as little as $25 a month with its savings offer, up to a maximum savings of $100 per month. Government beneficiaries are excluded, and your plan's terms set the final amount.
Does Medicare cover Wegovy for weight loss?
Under current law Medicare Part D does not cover obesity drugs, but Novo Nordisk says eligible patients pay $50 a month through the Medicare GLP-1 Bridge Program, with CMS setting eligibility. Part D covers Wegovy for cardiovascular risk reduction.
How long does prior authorization take?
Novo Nordisk says requests can take up to 10 business days. An approval can last from 30 days to more than a year, so ask your insurer when yours expires.
Does Medicaid cover GLP-1s for obesity?
Coverage is optional for states. KFF counted 13 state programs covering them for obesity under fee-for-service as of January 2026, and coverage is required for diabetes, cardiovascular disease and sleep apnea.
